S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

SRPT Sarepta Therapeutics Inc New

114.50

4.00 (3.62%)

23 Nov 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Sarepta Therapeutics Charts.

Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Sarepta Therapeutics Charts.

Sarepta Therapeutics Inc New News

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 21 November 2024 (3 days ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (1 week ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 week ago) • Edgar (US Regulatory)

Sarepta Therapeutics Announces Third Quarter 2024 Financial Results and Recent Corporate Developments
Thursday 7 November 2024 (2 weeks ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 1 November 2024 (3 weeks ago) • Business Wire

Sarepta Therapeutics to Announce Third Quarter 2024 Financial Results
Wednesday 23 October 2024 (1 month ago) • Business Wire

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 1 October 2024 (2 months ago) • Business Wire

Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2024 World Muscle Society Congress
Thursday 26 September 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Tuesday 17 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 16 September 2024 (2 months ago) • Edgar (US Regulatory)

More Sarepta Therapeutics Inc New News Articles

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions